Agilent Technologies Showcases New Solutions at Biopharmaceutical Symposium
January 26 2016 - 8:00AM
Business Wire
New AdvanceBio Columns Improve Laboratory
Workflows
Agilent Technologies Inc. (NYSE: A) is showcasing
innovative new technology this week designed to help scientists
achieve the reproducible results they need to develop effective
biopharmaceuticals.
The company is demonstrating its new line of AdvanceBio SEC
columns at the 20th Symposium on the Interface of Regulatory and
Analytical Sciences for Biotechnology Health Products (Twitter
hashtag #WCBP2016) today through Jan. 28 at the Mayflower Hotel in
Washington, D.C.
The new columns represent a significant advance in
size-exclusion chromatography, a key technology used to quantify
aggregation in biotherapeutics such as monoclonal antibodies.
Quantifying aggregation is a vital factor in developing and
producing safe, effective biologics.
AdvanceBio SEC columns deliver higher resolution for more
accurate quantitation as well as higher sensitivity to quantitate
aggregates, even at low levels.
“Through innovative design, AdvanceBio SEC columns deliver
reproducible results—column to column, batch to batch and lab to
lab,” said Helen Stimson, Agilent vice president and general
manager of the Chemistries and Supplies Division. “Our new silica
particle provides the resolution and stability to run shorter
columns at higher flow rates, giving laboratories the right result
in a quarter of the time.”
Stimson called the new columns an example of Agilent’s
dedication to designing new technologies to meet the challenges
faced by the biopharmaceutical industry.
“This product line will enable laboratories to control costs by
eliminating sample rework, simplifying method transfers and
improving lab productivity,” she said.
Product images are available at Agilent’s Life Sciences,
Diagnostics and Applied Markets Newsroom.
Agilent Events at WCBP 2016
Agilent will be at WCBP’s Booth No. 30. As a longtime premier
sponsor of this symposium, the company is pleased to showcase
several workflows for scientists working with biologics. Join
on-site specialists on topics ranging from the use of 2D HPLC/MS to
make the complex simple to automated platforms for sample
preparation needs. Agilent will have interactive virtual
instrumentation on display as well as the popular AssayMAP platform
in operation.
Agilent will present two technical seminars on Wednesday, Jan.
27. Seminar One, 12:30-1 p.m.: “Higher Order mAb Aggregate Analysis
Using New Innovative Size Exclusion Chromatography (SEC)
Technology,” with Ron Majors, LCGC magazine.
Seminar Two, 1-1:30 p.m.: “Simplifying 2D-LC, 2D-LC/MS Automated
Workflows: Fast and Efficient Multi-Dimension LC and LC/MS Method
Development.” For more information and to register for these
seminars, go to this link.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A), a global leader in
life sciences, diagnostics and applied chemical markets, is the
premier laboratory partner for a better world. Agilent works with
customers in more than 100 countries, providing instruments,
software, services and consumables for the entire laboratory
workflow. The company generated revenues of $4.04 billion in fiscal
2015 and employs about 12,000 people worldwide. Information about
Agilent is available at www.agilent.com.
NOTE TO EDITORS: Further technology, corporate citizenship and
executive news is available at www.agilent.com/go/news.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160126005125/en/
Agilent Technologies Inc.Michele Moyer, +1
408-553-7211michele.moyer@agilent.com
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Mar 2024 to Apr 2024
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Apr 2023 to Apr 2024